Licenses and licensing conditions may vary from country to country. Please always consult your country specific SPC or package leaflet.

Privacy at Baxter

In the regular course of business, Baxter interacts and communicates directly with consumers, patients, health-care professionals, employees and others. These audiences may share their personally identifiable information with Baxter which we collect, store and process electronically and/or manually. Please see the following Global Privacy Principles that govern Baxter´s use of personally identifiable information ("Private Information"). Since Baxter has many websites developed by Baxter business units and regions that can be accessed via the www.baxter.com site, please also see the information provided in the section entitled "Baxter´s Website Policies" below.

IMPORTANT: Baxter´s Global Privacy Statement states: "In all instances, Baxter believes that it is a person´s right to have their personal information kept private. Therefore, we have an obligation to implement privacy procedures and technical security measures to keep personal information private and secure." If you should have any questions concerning Baxter´s privacy practices or wish to access or correct Private Information that Baxter has collected from you, please submit an inquiry via Baxters on-line Privacy Inquiry Form, call: 1-800-422-9837 (847-948-4770) or fax your inquiry to 847-948-3642.

Are you a Healthcare Professional?


  I am not a Healthcare Professional            I am a Healthcare Professional

Please click "Accept" to continue:
Read & scroll down to accept the Policy Statement
Select Region:
Text Size:
Glossary  |  Site Map  |  Contact Us  |  News Room
BioTherapeutics Baxter wordmark link to corporate website

Therapeutic Areas | EU Overview

As a global healthcare company, BioTherapeutics is focused on saving and sustaining the lives of people with rare conditions. We are committed to providing therapies for patients across a broad range of treatment needs such as:

Immunoglobulins

Primary Immunodeficiencies and Secondary Immunodeficiencies

Please see SPC

WinRho SDF

Immune Thrombocytopenic Purpura

Please see SPCs

Ceprotin

Severe congenital Protein C deficiency

Please see SPC

Flexbumin

Treatment of hypovolemia

Please see SPCs

Licenses and licensing conditions may vary from country to country. Please always consult your country specific SPC or package leaflet.

In addition, Baxter is a committed partner to the primary immunodeficiencies community. Baxter supports the PID community to raise the awareness for PID issues and develop educational programs for physicians, nurses and patients. We work closely with the PID community and health policy makers on PID issues, in order to ensure that patients have continued access to care and treatment they require. In addition, we support Centers of Excellence for diagnosis and treatment in several countries to achieve earlier diagnosis of PID patients.

THERAPEUTIC AREAS